- Filed
- Mar 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 15, 2024 | 47.37M sh |
| Cash And Equivalents | Q1 2024 · Jan 31, 2024 | $489.5K |
| Cash And Equivalents | Q1 2024 · Oct 31, 2023 | $1.01M |
| Current Liabilities | Q1 2024 · Jan 31, 2024 | $429.16K |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $822.34K |
| Total Liabilities | Q1 2024 · Jan 31, 2024 | $577.33K |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $900.42K |
| Current Assets | Q1 2024 · Jan 31, 2024 | $800.39K |
| Current Assets | Q1 2024 · Oct 31, 2023 | $1.26M |
| Total Assets | Q1 2024 · Jan 31, 2024 | $6.04M |
| Total Assets | Q1 2024 · Oct 31, 2023 | $6.49M |
| Sga Expense | Q1 2024 · Jan 31, 2024 | $89.82K |
| Sga Expense | Q1 2024 · Jan 31, 2023 | $212.4K |
| Shares Diluted restated | Q1 2024 · Jan 31, 2023 | 35.06M sh |
| Operating Cash Flow | Q1 2024 · Jan 31, 2023 | −$140.92K |
| Stockholders Equity | Q1 2024 · Jan 31, 2023 | $5.58M |
| Stockholders Equity | Q1 2024 · Oct 31, 2022 | $5.87M |
| Eps Diluted | Q1 2024 · Jan 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Jan 31, 2023 | −$0.01 |
| Net Income | Q1 2024 · Jan 31, 2023 | −$345.87K |
| Operating Income | Q1 2024 · Jan 31, 2023 | −$348.82K |